KENNETH REAY CODE - 31 Dec 2021 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Science Officer, Director
Signature
/s/ John R. Browning, Attorney-in-fact
Issuer symbol
BLGO
Transactions as of
31 Dec 2021
Net transactions value
+$3,150
Form type
4
Filing time
04 Jan 2022, 16:49:13 UTC
Previous filing
06 Oct 2021
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLGO Common stock Award $3,150 +15,000 +0.06% $0.2100 24,596,095 31 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
F2 Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.